346 related articles for article (PubMed ID: 31990272)
21. Accelerated preclinical testing using transplanted tumors from genetically engineered mouse breast cancer models.
Varticovski L; Hollingshead MG; Robles AI; Wu X; Cherry J; Munroe DJ; Lukes L; Anver MR; Carter JP; Borgel SD; Stotler H; Bonomi CA; Nunez NP; Hursting SD; Qiao W; Deng CX; Green JE; Hunter KW; Merlino G; Steeg PS; Wakefield LM; Barrett JC
Clin Cancer Res; 2007 Apr; 13(7):2168-77. PubMed ID: 17404101
[TBL] [Abstract][Full Text] [Related]
22. Imaging TGFβ Signaling in Mouse Models of Cancer Metastasis.
Kang Y
Methods Mol Biol; 2016; 1344():219-32. PubMed ID: 26520127
[TBL] [Abstract][Full Text] [Related]
23. Effect of hydrocortisone on the macrophage content, growth and metastasis of transplanted murine tumors.
Acero R; Polentarutti N; Bottazzi B; Alberti S; Ricci MR; Bizzi A; Mantovani A
Int J Cancer; 1984 Jan; 33(1):95-105. PubMed ID: 6607223
[TBL] [Abstract][Full Text] [Related]
24. Immunological Consequences of Epithelial-Mesenchymal Transition in Tumor Progression.
Chockley PJ; Keshamouni VG
J Immunol; 2016 Aug; 197(3):691-8. PubMed ID: 27431984
[TBL] [Abstract][Full Text] [Related]
25. Intratumoral macrophages contribute to epithelial-mesenchymal transition in solid tumors.
Bonde AK; Tischler V; Kumar S; Soltermann A; Schwendener RA
BMC Cancer; 2012 Jan; 12():35. PubMed ID: 22273460
[TBL] [Abstract][Full Text] [Related]
26. EMT Transition States during Tumor Progression and Metastasis.
Pastushenko I; Blanpain C
Trends Cell Biol; 2019 Mar; 29(3):212-226. PubMed ID: 30594349
[TBL] [Abstract][Full Text] [Related]
27. Epithelial-mesenchymal transition and cell cooperativity in metastasis.
Tsuji T; Ibaragi S; Hu GF
Cancer Res; 2009 Sep; 69(18):7135-9. PubMed ID: 19738043
[TBL] [Abstract][Full Text] [Related]
28. Establishment of animal model for the analysis of cancer cell metastasis during radiotherapy.
Park JK; Jang SJ; Kang SW; Park S; Hwang SG; Kim WJ; Kang JH; Um HD
Radiat Oncol; 2012 Sep; 7():153. PubMed ID: 22963683
[TBL] [Abstract][Full Text] [Related]
29. A novel patient-derived orthotopic xenograft model of esophageal adenocarcinoma provides a platform for translational discoveries.
Veeranki OL; Tong Z; Mejia A; Verma A; Katkhuda R; Bassett R; Kim TB; Wang J; Lang W; Mino B; Solis L; Kingsley C; Norton W; Tailor R; Wu JY; Krishnan S; Lin SH; Blum M; Hofstetter W; Ajani J; Kopetz S; Maru D
Dis Model Mech; 2019 Dec; 12(12):. PubMed ID: 31732509
[TBL] [Abstract][Full Text] [Related]
30. TGFβ-derived immune modulatory vaccine: targeting the immunosuppressive and fibrotic tumor microenvironment in a murine model of pancreatic cancer.
Perez-Penco M; Weis-Banke SE; Schina A; Siersbæk M; Hübbe ML; Jørgensen MA; Lecoq I; Lara de la Torre L; Bendtsen SK; Martinenaite E; Holmström MO; Madsen DH; Donia M; Ødum N; Grøntved L; Andersen MH
J Immunother Cancer; 2022 Dec; 10(12):. PubMed ID: 36600556
[TBL] [Abstract][Full Text] [Related]
31. Targets of the tumor suppressor miR-200 in regulation of the epithelial-mesenchymal transition in cancer.
Schliekelman MJ; Gibbons DL; Faca VM; Creighton CJ; Rizvi ZH; Zhang Q; Wong CH; Wang H; Ungewiss C; Ahn YH; Shin DH; Kurie JM; Hanash SM
Cancer Res; 2011 Dec; 71(24):7670-82. PubMed ID: 21987723
[TBL] [Abstract][Full Text] [Related]
32. Lysosomal protein turnover contributes to the acquisition of TGFβ-1 induced invasive properties of mammary cancer cells.
Kern U; Wischnewski V; Biniossek ML; Schilling O; Reinheckel T
Mol Cancer; 2015 Feb; 14():39. PubMed ID: 25744631
[TBL] [Abstract][Full Text] [Related]
33. Tumor microenvironment and epithelial mesenchymal transition as targets to overcome tumor multidrug resistance.
Erin N; Grahovac J; Brozovic A; Efferth T
Drug Resist Updat; 2020 Dec; 53():100715. PubMed ID: 32679188
[TBL] [Abstract][Full Text] [Related]
34. Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumor.
Fifis T; Nguyen L; Malcontenti-Wilson C; Chan LS; Nunes Costa PL; Daruwalla J; Nikfarjam M; Muralidharan V; Waltham M; Thompson EW; Christophi C
Cancer Med; 2013 Oct; 2(5):595-610. PubMed ID: 24403226
[TBL] [Abstract][Full Text] [Related]
35. Epithelial-to-mesenchymal transition confers pericyte properties on cancer cells.
Shenoy AK; Jin Y; Luo H; Tang M; Pampo C; Shao R; Siemann DW; Wu L; Heldermon CD; Law BK; Chang LJ; Lu J
J Clin Invest; 2016 Nov; 126(11):4174-4186. PubMed ID: 27721239
[TBL] [Abstract][Full Text] [Related]
36. Nef-M1, a peptide antagonist of CXCR4, inhibits tumor angiogenesis and epithelial‑to‑mesenchymal transition in colon and breast cancers.
Katkoori VR; Basson MD; Bond VC; Manne U; Bumpers HL
Oncotarget; 2015 Sep; 6(29):27763-77. PubMed ID: 26318034
[TBL] [Abstract][Full Text] [Related]
37. PHD3 Controls Lung Cancer Metastasis and Resistance to EGFR Inhibitors through TGFα.
Dopeso H; Jiao HK; Cuesta AM; Henze AT; Jurida L; Kracht M; Acker-Palmer A; Garvalov BK; Acker T
Cancer Res; 2018 Apr; 78(7):1805-1819. PubMed ID: 29339541
[TBL] [Abstract][Full Text] [Related]
38. Organ-specific metastases in melanoma: experimental animal models.
Gattoni-Celli S; Byers RH; Calorini L; Ferrone S
Pigment Cell Res; 1993 Dec; 6(6):381-4. PubMed ID: 8146087
[TBL] [Abstract][Full Text] [Related]
39. Inhibition of uPAR-TGFβ crosstalk blocks MSC-dependent EMT in melanoma cells.
Laurenzana A; Biagioni A; Bianchini F; Peppicelli S; Chillà A; Margheri F; Luciani C; Pimpinelli N; Del Rosso M; Calorini L; Fibbi G
J Mol Med (Berl); 2015 Jul; 93(7):783-94. PubMed ID: 25694039
[TBL] [Abstract][Full Text] [Related]
40. Mutant p53 promotes epithelial-mesenchymal plasticity and enhances metastasis in mammary carcinomas of WAP-T mice.
Lenfert E; Maenz C; Heinlein C; Jannasch K; Schumacher U; Pantel K; Tolstonog GV; Deppert W; Wegwitz F
Int J Cancer; 2015 Mar; 136(6):E521-33. PubMed ID: 25195563
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
